Chargement en cours...
Modified Rheumatoid Arthritis Protocol for Rituximab in Pemphigus: A Retrospective Case Series
Background: Rituximab, an anticluster of differentation 20 antibody, has been shown in open series studies to be effective in treating pemphigus. In the literature, lymphoma (dose of 375mg/m(2), four-week infusion) and rheumatoid arthritis (two infusions of 1,000mg each, 15 days apart) are two proto...
Enregistré dans:
| Publié dans: | J Clin Aesthet Dermatol |
|---|---|
| Auteurs principaux: | , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Matrix Medical Communications
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7158908/ https://ncbi.nlm.nih.gov/pubmed/32308784 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|